In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
386 News Items found
Joey Laurore and Dr. Bob Li
Feature
For Some People with Cancer, a Simple Blood Test Can Be a Lifesaver

He was given a wrong diagnosis. A blood test changed his life.
Blue cells containing small red and green dots on a black background
In the Lab
Scientists Pinpoint a New Cause of Resistance to EGFR-Targeting Drugs

Multiple copies of a gene called <em>YES1</em> appear to be responsible for certain precision drugs losing their effectiveness.
Physician-scientist Piro Lito
In the Lab
Researchers Uncover New Findings about KRAS, an Important Protein in Cancer

Researchers have taken a closer look at what a protein called KRAS does in normal cells and how certain KRAS mutations lead to for cancer growth.
Illustration of a female doctor touching a strand of DNA
In the Clinic
New MSK Initiative Focuses on the Early Detection and Prevention of Cancer

Because cancer is more treatable when it’s caught early, MSK’s new Precision Interception and Prevention initiative focuses on early detection.
Cell Therapy and Cell Engineering Facility
Snapshot
T Cell Attack: Taking Down Cancer with Immunotherapy

MSK physician-scientist Prasad Adusumilli is focused on developing more-effective immunotherapy approaches for treating tumors in the chest.
Three photos of Karen Milich: one with her grandson, one of her with her sons, and one of her alone
Feature
How Four Decades of Research Led to an Important Advance in Lung Cancer

Read how a clinical trial is changing the outlook for some people with lung cancer.
Pictured: Tunneling Nanotubes
Snapshot
Tunneling Nanotubes Connect Cancer Cells

Memorial Sloan Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes.
American Society of Clinical Oncology logo
In the News
#ASCO17: Post-Conference Roundup of Themes and Trends

Read up on the progress being made in several key areas of cancer research, including immunotherapy, targeted therapy, precision surgery, and epigenetics.
MSK patient Ellen Coopersmith smiling in a rowboat in Central Park
MSK-Led Research Resulted in New FDA Approvals for Cancer Drugs in 2025

Learn about the clinical trials and research at MSK that led to FDA approvals in 2025, expanding treatment options for a range of different cancers.
A researcher working in an MSK lab
MSK Research Highlights, March 28, 2024

New MSK research helps win the approval of a drug to treat one type of metastatic non-small cell lung cancer; shows the effectiveness of cryoablation for large breast cancer tumors; identifies a gene essential for the formation of a common childhood brain tumor; and unlocks the secrets of natural killer cell metabolism.